Next |
home / stock / mcrb / mcrb message board
Subject | By | Source | When |
---|---|---|---|
$MCRB Perverse mkt action now. Candidate passed PDUFA | MiamiGent | investorshub | 04/28/2023 5:29:25 PM |
ARNA did that in the past- an offering | MiamiGent | investorshub | 04/28/2023 5:28:18 PM |
Why would they use debt financing rather than | Cosa | investorshub | 04/27/2023 7:48:05 PM |
$MCRB Another comment from another forum | MiamiGent | investorshub | 04/27/2023 3:38:53 PM |
. | MiamiGent | investorshub | 04/27/2023 3:19:40 PM |
. | MiamiGent | investorshub | 04/27/2023 3:19:00 PM |
$MCRB Reprinted from another forum | MiamiGent | investorshub | 04/27/2023 3:17:50 PM |
$MCRB Good morning all. | MiamiGent | investorshub | 04/27/2023 2:09:57 PM |
$MCRB We are #2 Trending, after META. | MiamiGent | investorshub | 04/27/2023 2:35:43 AM |
$MCRB Seres Therapeutics Inc | MiamiGent | investorshub | 04/26/2023 11:34:49 PM |
$MCRB I think we'll see some lift tomorrow. | MiamiGent | investorshub | 04/26/2023 11:01:30 PM |
US FDA approves Seres Therapeutics' pill for deadly | MiamiGent | investorshub | 04/26/2023 10:50:11 PM |
I though it would have a greater immediate | Cosa | investorshub | 04/26/2023 10:32:05 PM |
$MCRB Ok, news out. It passed! | MiamiGent | investorshub | 04/26/2023 10:23:39 PM |
$MCRB Quote | MiamiGent | investorshub | 04/26/2023 7:20:01 PM |
$MCRB PDUFA today | MiamiGent | investorshub | 04/26/2023 12:57:08 PM |
$MCRB countdown to tomorrow's PDUFA. Have you loaded? | MiamiGent | investorshub | 04/25/2023 1:57:37 PM |
$MCRB Wednesday PDUFA | MiamiGent | investorshub | 04/23/2023 11:14:45 PM |
MCRB In today for PDUFA next week. | MiamiGent | investorshub | 04/21/2023 8:23:45 PM |
========================= | Extremist223 | investorshub | 08/08/2022 7:16:41 PM |
News, Short Squeeze, Breakout and More Instantly...
Seres Therapeutics Inc. Company Name:
MCRB Stock Symbol:
NASDAQ Market:
Seres Therapeutics Inc. Website:
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
VOWST net sales of $10.4 million for the fourth quarter of 2023 and $19.6 million since launch in June through year-end 2023 Significant adoption of VOWST since launch in June 2023 through year-end 2023 with 2,833 patient enrollment forms received and 2,015 new patient starts ...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...